Business · 19/09/2024Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Nine Abbreviated New Drug Applications from Multiple Applicants, Including Allergan, Inc.
Summary
The Food and Drug Administration (FDA) has withdrawn the approval of nine abbreviated new drug applications (ANDAs) from multiple applicants, including Allergan, Inc., after the applicants notified the agency that the drug products were no longer in use.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →